SE419548B - Analogiforfarande for framstellning av 1-metyl-dihydrolysegoyl-nitroargininol-dekanoat - Google Patents

Analogiforfarande for framstellning av 1-metyl-dihydrolysegoyl-nitroargininol-dekanoat

Info

Publication number
SE419548B
SE419548B SE7505974A SE7505974A SE419548B SE 419548 B SE419548 B SE 419548B SE 7505974 A SE7505974 A SE 7505974A SE 7505974 A SE7505974 A SE 7505974A SE 419548 B SE419548 B SE 419548B
Authority
SE
Sweden
Prior art keywords
nitroargininol
dihydrolysegoyl
decanoate
methyl
preparation
Prior art date
Application number
SE7505974A
Other languages
English (en)
Swedish (sv)
Other versions
SE7505974L (sv
Inventor
E Mago
J Borsi
E Csanyi
K Pik
L Wolf
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE7505974L publication Critical patent/SE7505974L/xx
Publication of SE419548B publication Critical patent/SE419548B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7505974A 1974-05-28 1975-05-26 Analogiforfarande for framstellning av 1-metyl-dihydrolysegoyl-nitroargininol-dekanoat SE419548B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUGO1272A HU169073B (xx) 1974-05-28 1974-05-28

Publications (2)

Publication Number Publication Date
SE7505974L SE7505974L (sv) 1975-12-01
SE419548B true SE419548B (sv) 1981-08-10

Family

ID=10996767

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7505974A SE419548B (sv) 1974-05-28 1975-05-26 Analogiforfarande for framstellning av 1-metyl-dihydrolysegoyl-nitroargininol-dekanoat

Country Status (21)

Country Link
US (1) US4005089A (xx)
JP (1) JPS5218718B2 (xx)
AT (1) AT346501B (xx)
BE (1) BE829518A (xx)
BG (1) BG27374A3 (xx)
CA (1) CA1051878A (xx)
CS (1) CS194227B2 (xx)
DD (1) DD121639A5 (xx)
DE (1) DE2523743A1 (xx)
DK (1) DK143801C (xx)
ES (1) ES437994A1 (xx)
FI (1) FI61897C (xx)
FR (1) FR2272671B1 (xx)
GB (1) GB1474337A (xx)
HU (1) HU169073B (xx)
IL (1) IL47361A (xx)
NL (1) NL7506276A (xx)
PL (1) PL98944B1 (xx)
SE (1) SE419548B (xx)
SU (1) SU625612A3 (xx)
YU (1) YU135575A (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064249A (en) * 1974-05-28 1977-12-20 Richter Gedeon Vegyeszeti Gyar Rt. Compounds with ergoline skeleton
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
HU172479B (hu) * 1976-03-09 1978-09-28 Gyogyszerkutato Intezet Sposob poluchenija novykh soedinenij s ehrgolenovymi i
JPS577172Y2 (xx) * 1977-03-17 1982-02-10
JPS582957U (ja) * 1981-06-30 1983-01-10 松下電子工業株式会社 高圧ナトリウムランプ
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
DD238051A1 (de) * 1985-06-10 1986-08-06 Dresden Arzneimittel Verfahren zur herstellung neuer lysergsaeureamide
US8710092B2 (en) * 2009-12-23 2014-04-29 Map Pharmaceuticals, Inc. Substituted indolo 4,3 FG quinolines useful for treating migraine
BR112013033339A2 (pt) 2011-06-23 2016-08-16 Map Pharmaceuticals Inc análogos de fluorergolina
SG11201403434YA (en) 2011-12-19 2014-09-26 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
EP2793583A4 (en) 2011-12-21 2015-08-12 Map Pharmaceuticals Inc NOVEL NEUROMODULATORY CONNECTIONS
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
BR112017015487A2 (pt) 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo
BR112019025420A2 (pt) 2017-06-01 2020-06-16 Xoc Pharmaceuticals, Inc. Compostos policíclicos e usos destes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533699A (en) * 1950-12-12 Amines containing the king system
US2673850A (en) * 1951-07-28 1954-03-30 Sandoz Ag Piperazides of the lysergic acid series
US2946796A (en) * 1958-10-15 1960-07-26 Grace W R & Co Salts of ergot alkaloids
CH475252A (de) * 1966-02-08 1969-07-15 Sandoz Ag Verfahren zur Herstellung neuer Lysergsäure-Derivate
SE396753B (sv) * 1970-05-18 1977-10-03 Richter Gedeon Vegyeszet Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
US3901893A (en) * 1970-05-18 1975-08-26 Richter Gedeon Vegyeszet New dihydro-lysergic acid derivative
IL41409A (en) * 1972-02-04 1977-04-29 Richter Gedeon Vegyeszet Lysergic acid amides and process for their preparation

Also Published As

Publication number Publication date
NL7506276A (nl) 1975-12-02
ATA386375A (de) 1978-03-15
IL47361A0 (en) 1975-07-28
BG27374A3 (en) 1979-10-12
DD121639A5 (xx) 1976-08-12
DK143801C (da) 1982-03-22
FI61897B (fi) 1982-06-30
SE7505974L (sv) 1975-12-01
FR2272671B1 (xx) 1978-10-06
FI61897C (fi) 1982-10-11
CS194227B2 (en) 1979-11-30
GB1474337A (en) 1977-05-25
JPS5218718B2 (xx) 1977-05-24
CA1051878A (en) 1979-04-03
DK143801B (da) 1981-10-12
ES437994A1 (es) 1977-01-16
FR2272671A1 (xx) 1975-12-26
PL98944B1 (pl) 1978-05-31
HU169073B (xx) 1976-09-28
AU8142575A (en) 1976-11-25
FI751537A (xx) 1975-11-29
US4005089A (en) 1977-01-25
SU625612A3 (ru) 1978-09-25
IL47361A (en) 1979-11-30
AT346501B (de) 1978-11-10
BE829518A (fr) 1975-09-15
JPS516998A (xx) 1976-01-20
DK235175A (da) 1975-11-29
YU135575A (en) 1982-06-30
DE2523743A1 (de) 1975-12-18

Similar Documents

Publication Publication Date Title
SE420836B (sv) Analogiforfarande for framstellning av pyridazinyl-bensimidazoler
NO142401C (no) Analogifremgangsmaate til fremstilling av mavesyresekresjonshemmende 2-pyridylalkyltiobenzimidazoler
SE424320B (sv) Analogiforfarande for framstellning av derivat av 3-sulfonamido-4-amino-pyridiner
SE403630B (sv) Forfarande vid framstellning av flortyg
SE420095B (sv) Analogiforfarande for framstellning av 8-tiometyl-ergoliner
SE7513085L (sv) Forfarande for framstellning av etrar
TR19139A (tr) Laktatdehidrojenazenin izoenzimlerinin hepbirden tesbitine mahsus usul
SE419548B (sv) Analogiforfarande for framstellning av 1-metyl-dihydrolysegoyl-nitroargininol-dekanoat
NO146096C (no) Analogifremgangsmaate ved fremstilling av thienothiazinderivater
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE403703B (sv) Forfarande for framstellning av s-sulfonerade immunoglobuliner
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE425660B (sv) Analogiforfarande for framstellning av 1,4-dihydropyridiner
SE421921B (sv) Analogiforfarande for framstellning av pyridobensodiazepinoner
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
SE439008B (sv) Analogiforfarande for framstellning av spasmolytiska fenyletylaminoforeningar
SE421422B (sv) Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
SE430895B (sv) Forfarande for kontinuerlig framstellning av cellulosaglykolat
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE426827B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE422210B (sv) Analogiforfarande for framstellning av substituerade indoler
SE415658B (sv) Analogiforfarande for framstellning av linnolinderivat
SE425784B (sv) Analogiforfarande for framstellning av eburnameninderivat